Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LEXICON-PHARMACEUTICALS-I-9868/news/Lexicon-Pharmaceuticals-Completes-Enrollment-in-Pivotal-Phase-3-Clinical-Trial-of-Telotristat-Etip-20031770/?utm_source=whatsapp&utm_medium=social&utm_campaign=share